A New Chapter in mPharma’s Mission to Transform Africa’s Healthcare

mPharma, Ghana’s leading pharmaceutical technology startup, has announced the appointment of a new chief executive officer, marking a transition in leadership after 12 years at the helm. Gregory Rockson, the founder and former CEO, has stepped down from his role, though he will remain as the company’s chairman. The decision is part of the company’s strategic effort to strengthen leadership and scale operations across Africa.

Rockson, who co-founded mPharma in 2012, has been instrumental in transforming the startup into a key player in the continent’s healthcare innovation space. Under his leadership, the company developed an online platform connecting pharmacies with manufacturers and distributors to streamline drug supply chains. The platform now serves over 7,000 pharmacies across Ghana and has expanded into other African countries, including Nigeria and Kenya.

The new CEO, whose name has yet to be officially disclosed, will assume full responsibility for the company’s day-to-day operations, while Rockson will focus on long-term strategy and investor relations. mPharma described the leadership change as a “natural evolution” of the company’s growth strategy, with the aim of accelerating its mission to make essential medicines more accessible across the continent.

In a statement, Rockson expressed confidence in the company’s future and emphasized his commitment to supporting the new leadership. “mPharma has come a long way, but the work is far from over. I believe the next chapter will be even more impactful as we continue to scale our operations and improve healthcare access in Africa,” he said.

The leadership transition has been welcomed by key stakeholders in Ghana’s healthcare and technology sectors. Analysts have noted that mPharma’s continued success will depend on its ability to maintain strong relationships with pharmaceutical manufacturers, adopt emerging technologies, and navigate regulatory challenges across the continent. With its innovative business model and expanding footprint, the company is seen as a key player in addressing drug shortages and inefficiencies in Africa’s pharmaceutical supply chain.

title1 [url1]